Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and Perioperative Cognitive Function in Elderly Hypertensive Patients
ChiCTR-IPR-16009156Phase 4Recruiting
- Sponsor
- Department of Anesthesiology, First Affiliated Hospital of Inner Mongolia medical university
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in post-operative cognitive decline (POCD) and hypertension (HTN) (2 arms), sponsored by Department of Anesthesiology, First Affiliated Hospital of Inner Mongolia medical university. Primary endpoints: Mini-Mental State Examination (MMSE) scores, Interleukin-6 (IL-6) levels and 3 more. Started Sep 2016; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
post-operative cognitive decline (POCD)hypertension (HTN)
Beyond the preview
Go deeper on ChiCTR-IPR-16009156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16009156.